Home

Bolt Biotherapeutics, Inc. - Common Stock (BOLT)

5.1969
+0.2369 (4.78%)
NASDAQ · Last Trade: Oct 3rd, 1:33 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · October 2, 2025
Fidus Investment, Rocket Companies And Other Big Stocks Moving Lower In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 2, 2025
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 2, 2025
Why Concorde International Group Shares Are Trading Higher By 55%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · October 2, 2025
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · October 1, 2025
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · August 28, 2025
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · August 27, 2025
Bolt Revenue Jumps 39 Percent in Q2fool.com
Via The Motley Fool · August 14, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · August 1, 2025
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · June 4, 2025
Stay updated with the stocks that are on the move in today's after-hours session.chartmill.com
As the regular session of the US market concludes on Wednesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Via Chartmill · June 4, 2025
BOLT Stock Earnings: Bolt Biotherapeutics Misses EPS, Beats Revenue for Q2 2024investorplace.com
BOLT stock results show that Bolt Biotherapeutics missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 13, 2024
The Analyst Anxiety Index: 3 Stocks to Avoid as Uncertainty Growsinvestorplace.com
Explore key stocks with analyst uncertainty to avoid amid contrasting global market highs and risky downgrades.
Via InvestorPlace · May 24, 2024
Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Sessionbenzinga.com
Via Benzinga · May 15, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · May 15, 2024
This Accenture Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Todaybenzinga.com
Via Benzinga · May 15, 2024
Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · May 15, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · May 15, 2024
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesdayinvestorplace.com
We are covering the biggest pre-market stock movers for Wednesday with all of the latest happenings worth watching this morning!
Via InvestorPlace · May 15, 2024
BOLT Stock Earnings: Bolt Biotherapeutics Beats EPS, Beats Revenue for Q1 2024investorplace.com
BOLT stock results show that Bolt Biotherapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 14, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · May 14, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · April 3, 2024
BOLT Stock Earnings: Bolt Biotherapeutics Beats EPS, Beats Revenue for Q4 2023investorplace.com
BOLT stock results show that Bolt Biotherapeutics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 21, 2024
Why AERWINS Technologies Shares Are Trading Higher By Around 90%; Here Are 20 Stocks Moving Premarketbenzinga.com
Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares rose 90.2% to $0.2297 in pre-market trading. Aerwins Technologies is considering strategic alternatives for non-core operations including, not limited to possible sale/other disposition of assets.
Via Benzinga · October 2, 2023
Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2023benzinga.com
Via Benzinga · May 12, 2023